Dashboard providing the most recent information on data completeness and select performance indicators at the levels of NHS Trust and Cancer Alliance in England.

In our second State of the Nation Report, we focus on the care received by patients diagnosed with bowel cancer in England and Wales between 1 April 2022 and 31 March 2023, and the outcomes of treatment.

Patient friendly version of our State of the Nation report. This report includes people diagnosed with bowel cancer in England and Wales between 1 April 2022 and 31 March 2023.

Foreword for the State of the Nation Report 2024 written by Mr Justin Davies, ACPGBI President

Local Quality Improvement Action Plan for taking forward NBOCA State of the Nation report recommendations 2024

Supplementary results for the State of the Nation Report

This contains additional detailed information about the Methodology used within the State of the Nation Report.

Publication of the outlier responses for the State of the Nation Report is due later in January and February

Individual Trust/hospital/MDT results for the 2024 State of the Nation report are available here in an Excel spreadsheet.

Trusts were excluded from the State of the Nation report analyses if overall data completeness was less than 20% or ASA grade and/or TNM stage was missing in more than 80% of people included in the analyses.

This report includes patients diagnosed with bowel cancer in England and Wales between 1 April 2021 and 31 March 2022.

Patient friendly version of our State of the Nation report. This report includes patients diagnosed with bowel cancer in England and Wales between 1 April 2021 and 31 March 2022.

Supplementary results for the State of the Nation Report

This contains additional detailed information about the Methodology used within the State of the Nation Report.

Outlier responses for the State of the Nation Report

Individual Trust/hospital/MDT results for the 2023 State of the Nation report are available here in an Excel spreadsheet.

Trusts were excluded from the State of the Nation report analyses if overall data completeness was less than 20% or ASA grade and/or TNM stage was missing in more than 80% of patients included in the analyses.

Capturing transfer from theatre to critical care in linked national clinical datasets.

This report includes patients diagnosed with bowel cancer in England and Wales between 01 April 2020 and 31 March 2021, and patients diagnosed between 01 April 2019 and 31 March 2020 who underwent a major resection after 31 March 2020.

Patient friendly version of our annual report. This report includes patients diagnosed with bowel cancer in England and Wales between 01 April 2020 and 31 March 2021, and patients diagnosed between 01 April 2019 and 31 March 2020 who underwent a major resection after 31 March 2020.

This resource details the facilities available at each English hospital trust and Welsh MDT according to an organisational survey carried out in 2022.

Supplementary results for the 2022 Annual Report

Individual Trust/hospital/MDT results for the 2022 Annual Report are available here in an Excel spreadsheet.

This contains additional detailed information about the Methodology used within the 2022 Annual Report.

Outlier responses for the 2022 Annual Report

Short report on rectal surgery volume

The majority of the results in this report are for patients diagnosed 1 April 2019 to 31 March 2020. A separate section on the impact of COVID-19 covers patients diagnosed 1 March 2020 to 31 March 2021.

Patient friendly version of our annual report. Most of the results in this report are for patients diagnosed with bowel cancer between 1 April 2019 and 31 March 2020. A separate section on the impact of COVID-19 covers patients diagnosed 1 March 2020 to 31 March 2021.

This contains additional detailed information about the Methodology used within the 2021 Annual Report.

Individual Trust/hospital/MDT results for the 2021 Annual Report are available here in an Excel spreadsheet

Outlier responses for the 2021 Annual Report

Short report on patients diagnosed under 50 years old with metastatic colon cancer.

Published in December 2020, the majority of the results in this report are for patients diagnosed 1 April 2018 to 31 March 2019.

Individual Trust/hospital/MDT results for the 2020 Annual Report are available here in Excel spreadsheet format (previously contained within Annual Report appendix).

Outlier responses for the 2020 Annual Report are available here (previously contained within Annual Report appendix 2).

Patient friendly version of our main report which was published in December 2020. Most of the results in this report are for patients diagnosed with bowel cancer between 1 April 2018 and 31 March 2019.

This contains additional detailed information about the Methodology used within the 2020 Annual Report.

Short report on methodological development for the capture of chemotherapy from routine clinical data linked to NBOCA.

The feasibility of using the Cancer Patient Experience Survey for comparative performance monitoring as part of a national colorectal cancer audit.

Short report on the use of cancer registry data to improve case ascertainment.

Our 2019 Patient Report translated into Welsh.

Patient friendly version of our main report which was published in January 2020. Most of the results in this report are for patients diagnosed with bowel cancer between 1 April 2017 and 31 March 2018.

This resource details the facilities available at each English hospital trust and Welsh MDT according to an organisational survey carried out in 2019 including brand new sections on robotic surgery, genetics and advanced/recurrent disease management.

Published in January 2020, the majority of the results in this report are for patients diagnosed 1 April 2017 to 31 March 2018.

This contains additional detailed information about the Methodology used within the 2019 Annual Report.

Individual Trust/hospital/MDT results are available here in Excel spreadsheet format (previously contained within Annual Report appendix).

Short report on End of Life care.

Short report on the use of adjuvant chemotherapy for stage III colon cancer.

Excel spreadsheet containing all hospital/trust/MDT results for the 2018 annual report.

This resource details the facilities available at each English hospital trust and Welsh MDT according to an organisational survey carried out in 2018.

Published in December 2018, most of the results in this report are for patients diagnosed with bowel cancer between 1 April 2016 and 31 March 2017

Published in December 2018, the majority of the results in this report are for patients diagnosed 1 April 2016 to 31 March 2017.

We have produced a separate Methodology document for reference to help make the NBOCA annual report more concise.

A report detailing the feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit.

Published in December 2017, the majority of the results in this report are for patients diagnosed 1 April 2015 to 31 March 2016.

Published in December 2017, most of the results in this report are for patients diagnosed with bowel cancer between 1 April 2015 and 31 March 2016

Short report on the validaty of cancer-specific mortality as a performance indicator.

Table of facilities available at each trust/MDT according to an organisational survey carried out in 2017.

Short report on the optimal timing between radiotherapy and surgery in rectal cancer patients.

Published in December 2016, the majority of the results in this report are for patients diagnosed 1 April 2014 to 31 March 2015.

Published in December 2016, most of the results in this report are for patients diagnosed with bowel cancer between 1 April 2014 and 31 March 2015

Short report on the variation in length of hospital stay after major resection in patients with bowel cancer

Short report on access to liver resection in bowel cancer patients with liver metastases.

Table of facilities available at each trust/MDT according to an organisational survey carried out in 2016.

Published in 2015, the majority of the results in this report are for patients diagnosed 1 April 2013 to 31 March 2014.